Immune thrombocytopenia during the COVID-19 pandemic

Br J Haematol. 2021 Jun;193(6):1093-1095. doi: 10.1111/bjh.17457. Epub 2021 Apr 14.

Authors

Eun-Ju Lee¹, Xinguang Liu², Ming Hou², James B Bussel³

Affiliations

¹ Division of Hematology, New York Presbyterian Hospital - Weill Cornell, New York, NY, USA.
² Department of Hematology, Shandong University, Jinan, China.
³ Division of Pediatric Hematology/Oncology, New York Presbyterian Hospital - Weill Cornell, New York, NY, USA.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Aged
Aged, 80 and over
COVID-19 / complications*
Female
Humans
Male
Middle Aged
Retrospective Studies
Thrombocytopenia / complications
Thrombocytopenia / drug therapy*
Thrombocytopenia / physiopathology
Thrombocytopenia / therapy*
Young Adult